Phaos Technology Holdings (Cayman) (POAS) Non-Current Debt (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) posted Non-Current Debt of $49557.0 for Q4 2025, down 15.47% on a QoQ basis from $58625.9 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Non-Current Debt (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman)'s Non-Current Debt history runs 2 years deep, the most recent figure standing at $49557.0 for Q4 2025.

Quarterly Non-Current Debt changed N/A year-over-year to $49557.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $49557.0 (changed N/A YoY) and the FY2025 annual result came in at $58679.5, down 41.01% from the prior year.
Non-Current Debt was $49557.0 for Q4 2025 at Phaos Technology Holdings (Cayman), down from $58625.9 in the prior quarter.
Across five years, Non-Current Debt topped out at $99477.0 in Q2 2024 and bottomed at $49557.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	182.32 Bn	175.03 Bn	6.27 Bn	29.64 Bn
2	Stryker	128.82 Bn	125.95 Bn	3.81 Bn	14.22 Bn
3	Medtronic	108.46 Bn	99.24 Bn	6.41 Bn	26.17 Bn
4	Boston Scientific	68.25 Bn	66.79 Bn	3.61 Bn	10.99 Bn
5	Edwards Lifesciences	47.64 Bn	43.97 Bn	1.29 Bn	598.50 Mn
6	Dexcom	28.55 Bn	27.43 Bn	750.30 Mn	-
7	GE HealthCare Technologies	28.51 Bn	26.22 Bn	1.98 Bn	10.13 Bn
8	Smith & Nephew	26.96 Bn	26.39 Bn	-	3.18 Bn
9	Koninklijke Philips	25.42 Bn	22.29 Bn	2.07 Bn	8.07 Bn
10	Phaos Technology Holdings (Cayman)	6.17 Mn	6.12 Mn	-	49,557.00

Download Data